Precise Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.77 M
- Company Age 31 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 M
- Revenue Growth 3.53%
- Profit Growth 100.88%
- Ebitda 19.85%
- Net Worth 15.27%
- Total Assets -2.62%
About Precise Pharmaceuticals
Precise Pharmaceuticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 September 1993 and has a history of 31 years and four months. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.77 M.
The company currently has active open charges totaling ₹1.70 M.
Satish Soni and Aditya Soni serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74899PB1993PTC049546
-
Company No.
049546
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Sep 1993
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Precise Pharmaceuticals Private Limited offer?
Precise Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Nutraceuticals & Dietary Supplements, Mineral Supplement, Multivitamin Syrup & Drops, Nasal Drops, Antacid Drugs, Allopathic Liver Tonic, Pharma Franchise, Fungal Diastase Pepsin Syrup.
Who are the key members and board of directors at Precise Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Soni
|
Director | 27-Sep-1993 | Current |
|
Aditya Soni
|
Director | 25-Sep-2019 | Current |
Financial Performance of Precise Pharmaceuticals.
Precise Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 3.53% increase. The company also saw a substantial improvement in profitability, with a 100.88% increase in profit. The company's net worth Soared by an impressive increase of 15.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Precise Pharmaceuticals?
In 2021, Precise Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.70 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Patiala : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2000 | State Bank Of Patiala | ₹1.70 M | Open |
How Many Employees Work at Precise Pharmaceuticals?
Precise Pharmaceuticals has a workforce of 8 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Precise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Precise Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
